Daniel Ritz Selected Research

Antiviral Agents (Antivirals)

1/2022

Reduced IFN-ß inhibitory activity of Lagos bat virus phosphoproteins in human compared to Eidolon helvum bat cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Ritz Research Topics

Disease

7	Infections 05/2024 - 11/2006
4	Clostridium Infections 05/2024 - 01/2014
2	Inflammation (Inflammations) 01/2022 - 01/2013
2	Diarrhea 01/2014 - 01/2014
2	Persistent Infection 03/2010 - 06/2009
1	Hepatitis C 01/2013
1	Virus Diseases (Viral Diseases) 01/2011
1	Endocarditis 11/2006
1	Bacteremia 11/2006

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 11/2006
5	cadazolidIBA 05/2024 - 01/2014
2	InterferonsIBA 01/2022 - 01/2011
2	Oxazolidinones (2 Oxazolidone)IBA 01/2019 - 01/2014
2	RNA (Ribonucleic Acid)IBA 06/2015 - 01/2013
2	Interferon Type IIBA 12/2012 - 01/2011
2	bis(3',5')-cyclic diguanylic acidIBA 03/2010 - 06/2009
1	Antiviral Agents (Antivirals)IBA 01/2022
1	FluoroquinolonesIBA 01/2019
1	EnzymesIBA 03/2015
1	Peptide Hydrolases (Proteases)FDA Link 03/2015
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	Vancomycin FDA LinkGeneric 01/2014
1	Guanosine TetraphosphateIBA 06/2009
1	Daptomycin FDA Link 11/2006
1	LipopeptidesIBA 11/2006

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2009